In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Surgical Site Infection Rates in Shunted vs. Non-shunted Patients undergoing Craniotomy for Tumor with Cefazolin or Vancomycin Prophylaxis

    Final Number:
    4126

    Authors:
    Benjamin Flyer BS; Nolan D. Rea BS; Mark D. Krieger MD

    Study Design:
    Clinical trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2018 Annual Meeting - Late Breaking Science

    Introduction: Incidence of surgical site infection (SSI) among patients receiving craniotomy for tumor resection with a prior ventriculoperitoneal shunt is often higher than in non-shunted cases. Administering the proper antibiotic is necessary for the prevention of SSI for patients with and without shunts. We evaluated the infection rates of cefazolin and vancomycin for craniotomy for tumor patients with and without shunts.

    Methods: An IRB-approved multi-armed, retrospective analysis of data pertinent to craniotomy for tumor, shunt, and prophylactic antibiotics was employed to evaluate infection rate in 210 patients during a nine-year period. 168 patients given cefazolin and 42 patients given vancomycin were identified.

    Results: Overall infection rate was 5/210 (2.38%). Infection rate for craniotomies performed with a preexisting shunt was 2/27 (7.4%). There were no infections for patients with cefazolin and prior shunt (0/4), while vancomycin and prior shunt had an infection rate of 2/23 (8.70%). Patients receiving cefazolin and vancomycin with no prior shunt had infection rates of 2/164 (1.22%) and 1/19 (5.26%), respectively. Statistical analysis using a Fisher’s Exact Test resulted in a 2-sided significance value of 0.056, showing a trend towards significance at the 0.05 level given a greater power.

    Conclusions: Patients receiving vancomycin had higher incidence of infection. Moreover, regardless of prior shunt, vancomycin had a similar infection rate (8.70% prior shunt and 5.26% no prior shunt). Larger study size will help explore this problem.

    Patient Care: This research will help clinicians choose the appropriate prophylactic antibiotic for children undergoing craniotomies, with or without the presence of a preexisting shunt.

    Learning Objectives: By the conclusion of this session, particpiants should be able: 1. To identify a significant difference in infection rates between vancomycin and cefazolin. 2. To determine if prior shunting has any impact on infection rates following subsequent craniotomy. 3. To elucidate the efficacy of prophylactic antibiotics for craniotomy for tumor in consideration of prior shunt.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy